Dutch drugmaker Prosensa jumps 54 percent in U.S. stock market debut

(Reuters) - Dutch drugmaker Prosensa Holding received a buoyant welcome in its market debut on the Nasdaq, a day after U.S. health regulators granted a "breakthrough status" to its drug to treat a rare disease.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/-jvL8FYNepM/story01.htm

cheap phlebotomy training in california online phlebotomy training phlebotomy certification schools